期刊文献+
共找到51篇文章
< 1 2 3 >
每页显示 20 50 100
Design,delivery and efficacy testing of therapeutic nucleic acids used to inhibit hepatitis C virus gene expression in vitro and in vivo 被引量:9
1
作者 Wolfgang H.Caselmann Matthias Serwe +3 位作者 Thomas Lehmann János Ludwig Brian S.Sproat Joachim W.Engels 《World Journal of Gastroenterology》 SCIE CAS CSCD 2000年第5期626-629,共4页
Despite major achievements in the treatment ofchronic hepatitis C with the combination ofinterferons and the nucleoside analog ribavirin themajority of patients with chronic hepatitis C virus(HCV) infection cannot be ... Despite major achievements in the treatment ofchronic hepatitis C with the combination ofinterferons and the nucleoside analog ribavirin themajority of patients with chronic hepatitis C virus(HCV) infection cannot be treated effectively.Toimprove this response rate we used antisensetechnologies to inhibit HCV translation as possibleadditional option for experimental treatment.Antisense oligodeoxynucleotides(ODN) are 展开更多
关键词 hepatitis C-like viruses/therapy gene expression in VITRO in vivo nucleic acids/therapeutic use CYTOMEGALOVIRUS
下载PDF
Therapeutic and Medicinal Uses of <i>Aloe vera</i>: A Review 被引量:5
2
作者 Pankaj K. Sahu Deen Dayal Giri +5 位作者 Ritu Singh Priyanka Pandey Sharmistha Gupta Atul Kumar Shrivastava Ajay Kumar Kapil Dev Pandey 《Pharmacology & Pharmacy》 2013年第8期599-610,共12页
The plant Aloe vera is used in Ayurvedic, Homoeopathic and Allopathic streams of medicine, and not only tribal community but also most of the people for food and medicine. The plant leaves contains numerous vitamins, ... The plant Aloe vera is used in Ayurvedic, Homoeopathic and Allopathic streams of medicine, and not only tribal community but also most of the people for food and medicine. The plant leaves contains numerous vitamins, minerals, enzymes, amino acids, natural sugars and other bioactive compounds with emollient, purgative, anti-microbial, anti inflammatory, antioxidant, aphrodisiac, anti-helmenthic, antifungal, antiseptic and cosmetic values for health care. This plant has potential to cure sunburns, burns and minor cuts, and even skin cancer. The external use in cosmetic primarily acts as skin healer and prevents injury of epithelial tissues, cures acne and gives a youthful glow to skin, also acts as extremely powerful laxative. 展开更多
关键词 ALOE vera Antimicrobial therapeutic MEDICINAL useS Cosmetic Application
下载PDF
Continuous Wear of Hydrogel Contact Lenses for Therapeutic Use
3
作者 Daisuke Kudo Hiroshi Toshida +1 位作者 Toshihiko Ohta Akira Murakami 《Open Journal of Ophthalmology》 2012年第4期110-113,共4页
Purpose: To investigate the efficacy and complications of continuous wear of etafilcon A for therapeutic use. Materials and Methods: The subjects were 228 eyes of 219 outpatients prescribed contact lens (CL) for one w... Purpose: To investigate the efficacy and complications of continuous wear of etafilcon A for therapeutic use. Materials and Methods: The subjects were 228 eyes of 219 outpatients prescribed contact lens (CL) for one week of continuous therapeutic wear during 10 years. The reason for prescription of CLs, the primary disease, the duration of CL wear and the complications were assessed retrospectively. Results: The predominant reason for prescription of CLs was relief of pain or a foreign-body sensation (62.3%) and protection of the corneal epithelium (20.6%). The primary disease was post-penetrating keratoplasty (36.8%), followed by corneal epithelial erosion (14.5%), post-lamellar keratoplasty (14.0%) and bullous keratopathy (12.2%). The average duration of wearing single lens was 6.5 ± 3.2 days. The average duration of wearing CLs in total was 9.2 ± 10.7 months. The most frequent problem associated with continuous wear of CLs was their dropping out of CLs (12.3%). The complications associated with CLs included conjunctivitis with papillary hyperplasia, corneal erosion and superficial punctate keratitis, but corneal ulcer and corneal infiltrates were not found. Conclusion: Serious complications were not shown changing the lenses every week to keep to the prescribed time limit for continuous therapeutic wear, even if corneal epithelial barrier function is impaired. 展开更多
关键词 therapeutic use BANDAGE Soft Contact LENS CONTINUOUS WEAR COMPLICATION
下载PDF
Comparison of long-lasting therapeutic effects between succimer and penicillamine on hepatolenticular degeneration 被引量:3
4
作者 REN Ming Shan, ZHANG Zhi, WU Jun Xia, LI Fei, XUE Ben Chun and YANG Ren Min 《World Journal of Gastroenterology》 SCIE CAS CSCD 1998年第6期75-77,共3页
AIM To compare the long term effect of succimer (Suc) with that of penicillamine (Pen) in treating hepatolenticular degeneration (HLD). METHODS One hundred and twenty patients with HLD were divided into 2 groups. ... AIM To compare the long term effect of succimer (Suc) with that of penicillamine (Pen) in treating hepatolenticular degeneration (HLD). METHODS One hundred and twenty patients with HLD were divided into 2 groups. Group A ( n =60) received Suc 750mg , po. bid. Group B ( n =60) received Pen 250mg , po. qid. The period of maintenance treatment varied from 6 months to 3 years, averaging 1 5 years. Symptoms and therapeutic effects were evaluated by modified Goldstein scale. RESULTS The total effectiveness of group A in two different periods of treatment were 80% and 85% respectively, higher than those of group B (58% and 59% respectively) ( P <0 05). Suc also had obvious curative effects for the patients who failed in the use of Pen. There were fewer side effect in group A than in group B ( P <0 05). Suc and Pen could increase urinary copper excretion effectively and continually. CONCLUSION Suc is more effective and safer than Pen. Clinically, it can replace Pen as first choice drug for long term maintenance therapy of HLD. 展开更多
关键词 hepatolenticular degeneration/drug THERAPY succimer/therapeutic use penicillamine/therapeutic use
下载PDF
Functional dyspepsia of ulcer-dysmotility type:clinical incidence and therapeutic strategy 被引量:3
5
作者 WANG XiaoZhong and LIN GuZhen 《World Journal of Gastroenterology》 SCIE CAS CSCD 1998年第4期95-96,共2页
Functionaldyspepsiaofulcerdysmotilitytype:clinicalincidenceandtherapeuticstrategyWANGXiaoZhongandLINGuZhe... Functionaldyspepsiaofulcerdysmotilitytype:clinicalincidenceandtherapeuticstrategyWANGXiaoZhongandLINGuZhenSubjectheaadings... 展开更多
关键词 dyspepsia/drug therapy famotidine/therapeutic use cisapride/therapeutic use peptic ULCER gastrointestinal motility
下载PDF
Therapeutic role of template-based lymphadenectomy in urothelial carcinoma of the upper urinary tract 被引量:5
6
作者 Tsunenori Kondo Toshio Takagi Kazunari Tanabe 《World Journal of Clinical Oncology》 CAS 2015年第6期237-251,共15页
Lymphadenectomy for urothelial carcinoma of the upper urinary tract has attracted the attention of physicians. The mapping study of lymphatic spread has shown that a relatively wide area should comprise the regional n... Lymphadenectomy for urothelial carcinoma of the upper urinary tract has attracted the attention of physicians. The mapping study of lymphatic spread has shown that a relatively wide area should comprise the regional nodes for tumors of the right renal pelvis or the right upper two-thirds of the ureter. A prospective study showed that an anatomical templatebased lymphadenectomy significantly improved patient survival in tumors of the renal pelvis. This benefit was more evident for patients with p T2 stage tumors or higher. The risk of regional node recurrence is significant reduced by template-based lymphadenectomy,which is likely to be associated with improved patient survival. The removal of lymph node micrometastases is assumed to be the reason for therapeutic benefit following lymphadenectomy. The number of resected lymph nodes can be used to assess the quality of lymphadenectomy,but not to determine the extent of lymphadenectomy. The guidelines currently recommend lymphadenectomy for patients with muscle-invasive disease,even though the current recommendation grades are still low. The present limitation of lymphadenectomy is the lack of standardization of the extent of lymphadenectomy and the randomized trials. Further studies are warranted to collect the evidence to support lymphadenectomy. 展开更多
关键词 LYMPHADENECTOMY LYMPH node EXCISION UROTHELIAL carcinoma Treatment outcome therapeutic uses Diagnosis GUIDELINE
下载PDF
Blastocystis hominis as a cause of chronic diarrhea in low-resource settings:A systematic review
7
作者 Stephen Amoak Jonathan Soldera 《World Journal of Meta-Analysis》 2024年第3期30-41,共12页
BACKGROUND Blastocystis hominis(B.hominis),an anaerobic unicellular protist parasite,is known for its diverse clinical manifestations upon infecting the human gastrointestinal tract.Although globally distributed,it is... BACKGROUND Blastocystis hominis(B.hominis),an anaerobic unicellular protist parasite,is known for its diverse clinical manifestations upon infecting the human gastrointestinal tract.Although globally distributed,it is particularly prevalent in developing nations.Examining the symptoms and treatment outcomes of B.hominis infection in low-resource settings holds immense significance,providing healthcare practi-tioners with valuable insights to enhance patient care.AIM To synthesize existing evidence on the symptomatology and treatment outcomes of B.hominis infection in low-resource settings.METHODS Following the Preferred Reporting Items for Systematic Review and Meta-Analysis guidelines,a systematic review was conducted.The search spanned electronic databases including PubMed,Scopus,and Google Scholar.After a comprehensive screening process,a thorough examination of the papers,adhering to inclusion and exclusion criteria,and data extraction from eligible studies was conducted.The findings underwent summarization through simple descriptive analysis.RESULTS The search yielded 1200 papers,with 17 meeting inclusion criteria.Chronic diarrhea due to B.hominis infection was reported in only two studies,while abdominal pain,diarrhea,flatulence,constipation,and nausea/vomiting emerged as the most commonly documented symptoms.Recovery rates after one week of treatment ranged from 71.8%to 100%,and after two weeks,from 60%to 100%.CONCLUSION In low-resource settings,chronic diarrhea resulting from B.hominis infection is infrequent.Common symptoms include abdominal pain,diarrhea,flatulence,constipation,and nausea/vomiting.Post-treatment,clinical outcomes are notably favorable,supporting the recommendation for treatment.Metronidazole is advocated as the first-line agent,with consideration for switching to a second-line option in cases of treatment failure or poor response. 展开更多
关键词 Blastocystis infections Gastrointestinal diseases Treatment outcome Developing countries Metronidazole/therapeutic use
下载PDF
Clinacanthus nutans:a review of the medicinal uses,pharmacology and phytochemistry 被引量:10
8
作者 Md.Ariful Alam Sahena Ferdosh +4 位作者 Kashif Ghafoor Md.Abdul Hakim Abdul Shukor Juraimi Alfi Khatib Md.Zaidul I.Sarker 《Asian Pacific Journal of Tropical Medicine》 SCIE CAS 2016年第4期393-399,共7页
Clinacanthus nutans Lindau is known as snake grass belonging to the Acanlhaceae family.This plant has diverse and potential medicinal uses in traditional herbal medicine for treating skin rashes,insects and snake bite... Clinacanthus nutans Lindau is known as snake grass belonging to the Acanlhaceae family.This plant has diverse and potential medicinal uses in traditional herbal medicine for treating skin rashes,insects and snake bites,lesions caused by herpes simplex virus,diabetes,and gout in Malaysia.Indonesia.Thailand and China.Phylochemieal investigations documented the varied contents of bioaclive compounds from litis plant namely flavonoids,glycosides,glycoglyeerolipids.cerebrosides and monoacylmonogalatosylglycerol.The pharmacological experiment proved that various types of extracts and pure compounds from this species exhibited a broad range of biological properties such as anti-inflammatory,antiviral,antioxidant,and anti-diabetic activities.The lindings of toxicity study showed that extracts from this plant did not show any toxicity thus it can be used as strong therapeutic agents for specific diseased conditions.However,further experiments on chemical components and their mode of action showing biological activities are required to elucidate the complete phytochemical profile and assess to confirm their suitability tor future drugs.This review summarizes the medicinal uses,phytochemistry and pharmacology of this plant in order to explore its therapeutic potential and gaps necessitating for prospected research work. 展开更多
关键词 Clinacanthus nutans MEDICINAL useS PHYTOCHEMICALS PHARMACOLOGY therapeutic potential
下载PDF
High-intensity focused ultrasound extracorporeal ablation of liver tissuesin rabbits
9
《World Journal of Gastroenterology》 SCIE CAS CSCD 1998年第2期16-16,共1页
HighintensityfocusedultrasoundextracorporealablationoflivertissuesinrabbitsCHENGShuQun1,ZHOUXinDa1,TANGZ... HighintensityfocusedultrasoundextracorporealablationoflivertissuesinrabbitsCHENGShuQun1,ZHOUXinDa1,TANGZhaoYou1,YUYao1,B... 展开更多
关键词 LIVER neoplasms experimental/therapy ultrasonic THERAPY iodized oil/therapeutic use liver/radiation effects randomized controlled trials
下载PDF
Controversies regarding transplantation of mesenchymal stem cells
10
作者 Tsvetelina Velikova Tereza Dekova Dimitrina Georgieva Miteva 《World Journal of Transplantation》 2024年第2期48-61,共14页
Mesenchymal stem cells(MSCs)have tantalized regenerative medicine with their therapeutic potential,yet a cloud of controversies looms over their clinical tran-splantation.This comprehensive review navigates the intric... Mesenchymal stem cells(MSCs)have tantalized regenerative medicine with their therapeutic potential,yet a cloud of controversies looms over their clinical tran-splantation.This comprehensive review navigates the intricate landscape of MSC controversies,drawing upon 15 years of clinical experience and research.We delve into the fundamental properties of MSCs,exploring their unique immuno-modulatory capabilities and surface markers.The heart of our inquiry lies in the controversial applications of MSC transplantation,including the perennial debate between autologous and allogeneic sources,concerns about efficacy,and lingering safety apprehensions.Moreover,we unravel the enigmatic mechanisms surro-unding MSC transplantation,such as homing,integration,and the delicate balance between differentiation and paracrine effects.We also assess the current status of clinical trials and the ever-evolving regulatory landscape.As we peer into the future,we examine emerging trends,envisioning personalized medicine and innovative delivery methods.Our review provides a balanced and informed perspective on the controversies,offering readers a clear understanding of the complexities,challenges,and potential solutions in MSC transplantation. 展开更多
关键词 Mesenchymal stem cells Transplantation controversies Regenerative medicine Autoimmune diseases Chronic inflammatory illnesses Tumor growth METASTASIS therapeutic potential Clinical use of mesenchymal stem cell
下载PDF
USE OF CELL-BASED BIOASSAY FOR THE QUALITY CONTROL OF BOTANICAL THERAPEUTICS
11
作者 Doo Suk Lee Min-Jung Bae Sunyoung Kim 《World Journal of Traditional Chinese Medicine》 2015年第4期91-91,共1页
The single most important factor in modernization efforts of traditional oriental medicines is the limited understanding of active compounds responsible for claimed therapeutic effects.Indeed,the unknown identity of b... The single most important factor in modernization efforts of traditional oriental medicines is the limited understanding of active compounds responsible for claimed therapeutic effects.Indeed,the unknown identity of biologically active molecules generates major difficulties associated with botanical therapeutics in general.This includes management of raw materials,poor understanding of 展开更多
关键词 use OF CELL-BASED BIOASSAY FOR THE QUALITY CONTROL OF BOTANICAL therapeuticS PG
原文传递
布地奈德鼻喷雾剂联合孟鲁司特钠治疗变应性鼻炎的疗效观察 被引量:18
12
作者 詹飞 陈锋 《河北医学》 CAS 2018年第7期1210-1213,共4页
目的:探讨布地奈德鼻喷雾剂联合孟鲁司特钠治疗变应性鼻炎的疗效。方法:收集我院2013年9月至2015年5月收治的变应性鼻炎患者90例前瞻性研究且随机分为两组,每组45人,A组患者给予布地奈德+氯雷他定,B组患者给予布地奈德+孟鲁司特钠,比较... 目的:探讨布地奈德鼻喷雾剂联合孟鲁司特钠治疗变应性鼻炎的疗效。方法:收集我院2013年9月至2015年5月收治的变应性鼻炎患者90例前瞻性研究且随机分为两组,每组45人,A组患者给予布地奈德+氯雷他定,B组患者给予布地奈德+孟鲁司特钠,比较两组患者临床症状评分与治疗效果。结果:A组患者治疗后鼻塞评分(0.81±0.18)、鼻痒评分(0.61±0.19)、喷嚏评分(0.57±0.15)与流涕评分(0.34±0.13)均显著性高于B组(0.56±0.15,0.46±0.11,0.41±0.12,0.21±0.08),存在显著性差异(t=12.451,9.261,7.051,5.337),具有统计学意义(P<0.01);A组患者总有效率(75.56%)明显低于B组(93.33%),存在明显差异(χ2=5.414),具有统计学意义(P<0.05)。结论:相比较布地奈德+氯雷他定的治疗效果,布地奈德+孟鲁司特钠对变应性鼻炎患者治疗最为显著,具有借鉴性。 展开更多
关键词 布地奈德 氯雷他定 孟鲁司特钠 疗效
下载PDF
甲基丁香酚对变应性鼻炎大鼠鼻黏膜组织中黏蛋白5AC的影响 被引量:6
13
作者 孟楠楠 侯赟 +5 位作者 桂岩 席克虎 王有虎 杨静 陈虹 张小兵 《浙江大学学报(医学版)》 CAS CSCD 北大核心 2016年第5期477-485,共9页
目的:观察甲基丁香酚对变应性鼻炎大鼠鼻黏膜中黏蛋白5AC(MUC5AC)的影响。方法:将72只Wistar大鼠分为正常对照组(12只)和造模组(60只),卵清蛋白致敏Wistar大鼠建立变态性鼻炎动物模型。造模成功后,大鼠随机分为模型对照组、... 目的:观察甲基丁香酚对变应性鼻炎大鼠鼻黏膜中黏蛋白5AC(MUC5AC)的影响。方法:将72只Wistar大鼠分为正常对照组(12只)和造模组(60只),卵清蛋白致敏Wistar大鼠建立变态性鼻炎动物模型。造模成功后,大鼠随机分为模型对照组、氯雷他定组和甲基丁香酚小、中、大剂量组(10mg/kg、20mg/kg、40mg/kg),各组给药干预,分别在干预l周、2周、4周和6周后取材,采用免疫组织化学检测和实时定量PCR检测MUC5ACmRNA及其蛋白的表达。结果:MUC5AC蛋白阳性表达细胞百分率及MUC5ACmRNA表达量小剂量组在整个干预过程中与模型对照组差异无统计学意义(均P〉0.05);大、中剂量组分别在干预2周和4周后明显减少,差异均有统计学意义(均P〈0.05);氯雷他定组在干预1周后明显减少,差异有统计学意义(P〈0.05)。与氯雷他定组MUC5AC蛋白阳性表达细胞百分率比较:中剂量组在干预6周后依然较高(P〈0.05),大剂量组在干预6周后差异无统计学意义(P〉0.05)。与氯雷他定组MUC5ACmRNA表达量比较,大、中剂量组在干预4周后差异均无统计学意义(均P〉0.05)。结论:甲基丁香酚可以显著抑制变应性鼻炎大鼠鼻黏膜中黏蛋白MUC5AC的表达,进而对变应性鼻炎有一定的抑制作用,可为临床应用研究提供依据。 展开更多
关键词 丁香酚/药理学 丁香酚/投药和剂量 鼻炎/药物疗法 氯雷他定/治疗 应用 黏蛋白类/药物作用 鼻黏膜/药物作用 大鼠 Wistar
下载PDF
开瑞坦治疗小儿外耳道湿疹的疗效观察 被引量:2
14
作者 徐宏胜 江刚 +2 位作者 文忠 刘银红 郭梦和 《中国中西医结合耳鼻咽喉科杂志》 2008年第5期344-345,共2页
目的评价第三代抗组胺药开瑞坦对小儿外耳道湿疹的临床疗效。方法外耳道湿疹患儿34例(43耳),随机分为治疗组(18例,22耳)和对照组(16例,21耳)。治疗组口服开瑞坦,对照组口服扑尔敏,两组患儿均局部外涂复方酮康唑氧氟沙星软膏,观察比较疗... 目的评价第三代抗组胺药开瑞坦对小儿外耳道湿疹的临床疗效。方法外耳道湿疹患儿34例(43耳),随机分为治疗组(18例,22耳)和对照组(16例,21耳)。治疗组口服开瑞坦,对照组口服扑尔敏,两组患儿均局部外涂复方酮康唑氧氟沙星软膏,观察比较疗效差异。结果治疗组和对照组的痊愈率分别为86.4%和57.1%(P<0.05)。痊愈病例随访1个月,其复发率分别为21.1%和66.7%(P<0.05)。两组患儿均无严重的不良反应发生。结论开瑞坦用于小儿外耳道湿疹的治疗具有疗效好、副作用少、服用方便的特点,值得推广应用。 展开更多
关键词 外耳道湿疹 儿童 开瑞坦 疗效
下载PDF
氯雷他啶片剂及胶囊生物等效的研究
15
作者 马霖 刘月芬 韩志武 《青岛大学医学院学报》 CAS 2003年第2期194-196,共3页
①目的 评价受试制剂氯雷他啶片剂和胶囊与参比制剂市销氯雷他啶片 (开瑞坦 )是否生物等效 ,为申报新药及临床应用提供实验依据。②方法 选择 1 8名男性健康受试者 ,单剂三交叉口服试验制剂氯雷他啶片剂、氯雷他啶胶囊以及参比制剂开... ①目的 评价受试制剂氯雷他啶片剂和胶囊与参比制剂市销氯雷他啶片 (开瑞坦 )是否生物等效 ,为申报新药及临床应用提供实验依据。②方法 选择 1 8名男性健康受试者 ,单剂三交叉口服试验制剂氯雷他啶片剂、氯雷他啶胶囊以及参比制剂开瑞坦各 2 0mg ,应用液质联用法测定服药前和服药后 0 .33、0 .6 7、1 .0 0、1 .5 0、2 .0 0、3.0 0、4 .0 0、6 .0 0、8.0 0、1 2 .0 0、2 4 .0 0h血药浓度 ,计算主要药动学参数 ,评价受试制剂与参比制剂的生物等效性。③结果 受试制剂氯雷他啶片剂、胶囊和参比制剂的AUC0~t分别为 38.79、38.4 0、37.0 2g·h·L-1 ,血药峰值浓度 (Cmax)分别为 1 3.73、1 3.76、1 3.91 μg/L ,血药峰值时间 (Tmax)分别为 1 .33、1 .1 7、1 .2 4h ,半衰期 (T1 /2 )分别为 4 .4 3、4 .90、4 .38h ,AUC0~∞ 分别为 4 0 .83、4 0 .6 7、38.74g·h·L-1 。受试制剂氯雷他啶片的相对生物利用度为1 0 4 .78% ,受试制剂氯雷他啶胶囊的相对生物利用度为 1 0 3.73%。AUC0~t、AUC0~∞ 和Cmax经双单侧t检验和 (1- 2α)置信区间检验无显著差异。 展开更多
关键词 氯雷他啶 片剂 胶囊 生物等效 碎片质谱法 抗组胺药
下载PDF
糖皮质激素分别联合氯雷他定与孟鲁司特治疗持续性中重度变应性鼻炎的疗效比较 被引量:4
16
作者 方忠泓 陈伟龙 +1 位作者 陈声伟 陈伟东 《临床合理用药杂志》 2022年第22期35-38,共4页
目的比较糖皮质激素分别联合氯雷他定与孟鲁司特治疗持续性中重度变应性鼻炎的疗效。方法回顾性选取2018年3月—2019年3月在汕头市澄海区人民医院就诊的持续性中重度变应性鼻炎患者100例作为研究对象,按照治疗方法不同分为氯雷他定组(n=... 目的比较糖皮质激素分别联合氯雷他定与孟鲁司特治疗持续性中重度变应性鼻炎的疗效。方法回顾性选取2018年3月—2019年3月在汕头市澄海区人民医院就诊的持续性中重度变应性鼻炎患者100例作为研究对象,按照治疗方法不同分为氯雷他定组(n=50)和孟鲁司特组(n=50)。氯雷他定组采用糖皮质激素联合氯雷他定治疗,孟鲁司特组采用糖皮质激素联合孟鲁司特治疗,2组患者均治疗2周。比较2组患者临床疗效、治疗前后各项症状(鼻阻、鼻痒、流涕、喷嚏)评分、总症状评分、血清特异性抗体IgE、鼻腔分泌物嗜酸粒细胞(EOS)阳性率及不良反应。结果治疗2周后,氯雷他定组与孟鲁司特组患者总有效率比较差异无统计学意义(90.00%vs.98.00%,χ^(2)=1.596,P=0.207);2组患者各项症状评分及总症状评分均较治疗前明显降低(P<0.01);孟鲁司特组患者鼻阻症状评分低于氯雷他定组(P<0.01),鼻痒、喷嚏症状评分高于氯雷他定组(P<0.01);2组患者流涕评分及总症状评分比较差异均无统计学意义(P>0.05);2组患者血清特异性抗体IgE及鼻腔分泌物EOS阳性率均低于治疗前(P<0.01),2组比较差异无统计学意义(P>0.05)。2组患者不良反应总发生率比较差异无统计学意义(2.00%vs.4.00%,χ^(2)=0.345,P=0.558)。结论糖皮质激素分别联合氯雷他定与孟鲁司特治疗持续性中重度变应性鼻炎的疗效均较好,糖皮质激素联合孟鲁司特缓解鼻阻效果略优,糖皮质激素联合氯雷他定更有利于缓解鼻痒及喷嚏症状,两种药物均可有效缓解持续性中重度变应性鼻炎患者的临床症状,降低血清特异性IgE及鼻腔分泌物EOS阳性率,且不良反应较少,应根据患者病情合理选择用药。 展开更多
关键词 变应性鼻炎 中重度 糖皮质激素 氯雷他定 孟鲁司特 治疗效果
下载PDF
酮替芬联合氯雷他定对小儿咳嗽变异性哮喘的治疗作用研究 被引量:2
17
作者 郑敏斯 何德根 欧彩香 《吉林医学》 CAS 2018年第4期672-673,共2页
目的:探讨酮替芬联合氯雷他定对小儿咳嗽变异性哮喘的治疗作用。方法:选取咳嗽变异性哮喘患儿82例,随机分为对照组和观察组,各41例。对照组患儿采用酮替芬治疗,观察组在对照组基础上联合氯雷他定治疗,对比两组临床疗效、哮喘及咳嗽症状... 目的:探讨酮替芬联合氯雷他定对小儿咳嗽变异性哮喘的治疗作用。方法:选取咳嗽变异性哮喘患儿82例,随机分为对照组和观察组,各41例。对照组患儿采用酮替芬治疗,观察组在对照组基础上联合氯雷他定治疗,对比两组临床疗效、哮喘及咳嗽症状消失时间和不良反应情况。结果:观察组总有效率(95.12%)显著高于对照组的(78.05%),差异有统计学意义(P<0.05)。观察组哮喘症状消失时间(9.12±2.13)d、咳嗽症状消失时间(14.62±2.69)d均显著少于对照组(13.51±3.47)d、(18.53±3.58)d,差异有统计学意义(P<0.05)。观察组患儿不良反应发生率(17.07%)略高于对照组(12.20%),但差异无统计学意义(P>0.05)。结论:小儿咳嗽变异性哮喘采用酮替芬加氯雷他定方案治疗效果可靠,具有起效快、疗效好、安全性高等优势,值得推广借鉴。 展开更多
关键词 酮替芬 氯雷他定 小儿咳嗽变异性哮喘 治疗作用
下载PDF
Combination of "low-dose" ribavirin and interferon alfa-2a therapy followed by interferon alfa-2a monotherapy in chronic HCV-infected nonresponders and relapsers after interferon alfa-2a monotherapy 被引量:19
18
作者 Perdita Wietzke-Braun Volker Meier +1 位作者 Felix Braun Giuliano Ramadori 《World Journal of Gastroenterology》 SCIE CAS CSCD 2001年第2期222-227,共6页
AIM To report on the efficacy, safety and tolerability of interferon alfa-2a combined with a "low dose" of ribavirin for relapsers and non responders to alpha interferon monotherapy.METHODS Thirty-four chron... AIM To report on the efficacy, safety and tolerability of interferon alfa-2a combined with a "low dose" of ribavirin for relapsers and non responders to alpha interferon monotherapy.METHODS Thirty-four chronic hepatitis C virus-infected non-responders to interferon alfa2a monotherapy (a course of at least 3 months treatment) and 13 relapsers to interferon alfa 2a monotherapy (a dose of 3 to 6 million units three times per week for at least 20 weeks but not more than 18 months) were treated with the same dose of interferon alfa-2a used before (3 to 6 million units three times per week) and ribavirin (10 mg/ kg daily) for 6 months. In complete responders, interferon alfa-2a was administered for further 6 months at the same dose used before as monotherapy.RESULTS Seven (20.6%) of 34 non-responders stopped the combined therapy due to adverse events, including two patients with histological and clinical Child A cirrhosis. In 17/27 (63%)non-responders, the combined therapy was stopped after three months because of non-response. Ten of the 27 non-responders completed the 1;2-month treatment course. At a mean follow up of 28 months (16- 37 months)after the treatment, 4/10 (15%) previous non-responders still remained complete responders,All 13 previous relapsers completed the 12-month treatment course. At a mean follow up of 22months (9 - 36 months) after treatment, 6/13(46%) the previous relapsers were stillsustained complete responders.CONCLUSION Our treatment schedule of the combined therapy for 6 months of interferon alfa2a with a low dose of ribavirin (10 mg/kg/day)followed by 6 months of interferon alfa-2amonotherapy is able to induce a sustainedcomplete response rate in 15% of non-responders and 46% of relapsers with chronic hepatitis C virus-related liver diseases comparable to those obtained with the standarddoses of ribavirin 1000 - 1200 mg/day.Randomized prospective controlled trials using lower total amounts of ribavirin in combination with interferon should be performed. 展开更多
关键词 hepatitis C chronic/drug therapy INTERFERON alpha-2a/therapeutic use INTERFERON alpha-2a/administration & DOSAGE ribavirin/administration & DOSAGE ribavirin/therapeutic use
下载PDF
Probiotic mixture VSL#3:An overview of basic and clinical studies in chronic diseases 被引量:11
19
作者 Fang-Shu Cheng Dan Pan +2 位作者 Bing Chang Min Jiang Li-Xuan Sang 《World Journal of Clinical Cases》 SCIE 2020年第8期1361-1384,共24页
Probiotics are known as“live microorganisms”and have been proven to have a health effect on hosts at the proper dose.Recently,a kind of probiotic mixture including eight live bacterial strains,VSL#3,has attracted co... Probiotics are known as“live microorganisms”and have been proven to have a health effect on hosts at the proper dose.Recently,a kind of probiotic mixture including eight live bacterial strains,VSL#3,has attracted considerable attention for its combined effect.VSL#3 is the only probiotic considered as a kind of medical food;it mainly participates in the regulation of the intestinal barrier function,including improving tight junction protein function,balancing intestinal microbial composition,regulating immune-related cytokine expression and so on.The objective of this review is to discuss the treatment action and mechanism for the administration of VSL#3 in chronic diseases of animals and humans(including children).We found that VSL#3 has a therapeutic or preventive effect in various systemic diseases per a large number of studies,including digestive systemic diseases(gastrointestinal diseases and hepatic diseases),obesity and diabetes,allergic diseases,nervous systemic diseases,atherosclerosis,bone diseases,and female reproductive systemic diseases. 展开更多
关键词 VSL#3 INTESTINAL barrier function CHRONIC DISEASES INTESTINAL MICROBIAL balance CYTOKINES therapeutic use
下载PDF
Medicinal plants with hepatoprotective activity in Iranian folk medicine 被引量:5
20
作者 Majid Asadi-Samani Najme Kafash-Farkhad +3 位作者 Nafiseh Azimi Ali Fasihi Ebrahim Alinia-Ahandani Mahmoud Rafieian-Kopaei 《Asian Pacific Journal of Tropical Biomedicine》 SCIE CAS 2015年第2期146-157,共12页
There are a number of medicinal combinations in the Iranian traditional medicine which are commonly used as tonic for liver.In this review,we have introduced some medicinal plants that are used mainly for the treatmen... There are a number of medicinal combinations in the Iranian traditional medicine which are commonly used as tonic for liver.In this review,we have introduced some medicinal plants that are used mainly for the treatment of liver disorders in Iranian folk medicine,with focus on their hepatoprotective effects particularly against CCI_4 agent.In this study,online databases including Web of Science.PubMed.Scopus,and Science Direct were searched for papers published from January 1970 to December 2013.Search terms consisted of medicinal plants,traditional medicine,folk medicine,hepatoprotective.Iran,liver,therapeutic uses,compounds,antioxidant.CCI_4.anti-inflammatory,and antihepatotoxic,hepatitis,alone or in combination.Allium hirtifolium Boiss..Apium graveolens L..Cynara scolyinus.Berberis vulgaris L..,Calendula officinalis,Nigella sativa L..Taraxacum officinale.Tragopogon porrifolius.Prangos ferulacea L..Allium sativum,Marribium vulgare,Ammi majus L..Citrullus lanatus Thunb.Agrimonia eupatoria L.and Primus armeniaca L.are some of the medicinal plants that have been used for the treatment of liver disorders in Iranian folk medicine.Out of several leads obtained from plants containing potential hepatoprotective agents,silymarin,P-sitosterol,betalain,neoandrographolide.phyllanthin.andrographolide.curcumin.picroside.hypophyllanlhin.kutkoside,and glycyrrhizin have been demonstrated to have potent hepatoprotective properties.Despite encouraging data on possibility of new discoveries in the near future,the evidence on treating viral hepatitis or other chronic liver diseases by herbal medications is not adequate. 展开更多
关键词 Medicinal plants Iran COMPOUNDS LIVER therapeutic uses CCl_4
下载PDF
上一页 1 2 3 下一页 到第
使用帮助 返回顶部